122 related articles for article (PubMed ID: 21205088)
1. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
[TBL] [Abstract][Full Text] [Related]
2. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
[TBL] [Abstract][Full Text] [Related]
3. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor-induced phosphorylation of STAP-2 on tyrosine-250 is involved in its STAT3-enhancing activity.
Sekine Y; Tsuji S; Ikeda O; Kakisaka M; Sugiyama K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2007 May; 356(2):517-22. PubMed ID: 17368569
[TBL] [Abstract][Full Text] [Related]
5. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
[TBL] [Abstract][Full Text] [Related]
6. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Brk kinase and insulin receptor substrate-4.
Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
[TBL] [Abstract][Full Text] [Related]
9. Possible Therapeutic Applications of Targeting STAP Proteins in Cancer.
Matsuda T; Oritani K
Biol Pharm Bull; 2021; 44(12):1810-1818. PubMed ID: 34853263
[TBL] [Abstract][Full Text] [Related]
10. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
11. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
12. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.
Mitchell PJ; Sara EA; Crompton MR
Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601
[TBL] [Abstract][Full Text] [Related]
13. Role of the Brk SH3 domain in substrate recognition.
Qiu H; Miller WT
Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
[TBL] [Abstract][Full Text] [Related]
14. Identification of STAT3 as a specific substrate of breast tumor kinase.
Liu L; Gao Y; Qiu H; Miller WT; Poli V; Reich NC
Oncogene; 2006 Aug; 25(35):4904-12. PubMed ID: 16568091
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Lukong KE; Larocque D; Tyner AL; Richard S
J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
[TBL] [Abstract][Full Text] [Related]
16. STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif.
Minoguchi M; Minoguchi S; Aki D; Joo A; Yamamoto T; Yumioka T; Matsuda T; Yoshimura A
J Biol Chem; 2003 Mar; 278(13):11182-9. PubMed ID: 12540842
[TBL] [Abstract][Full Text] [Related]
17. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
[TBL] [Abstract][Full Text] [Related]
18. STAP-2 regulates c-Fms/M-CSF receptor signaling in murine macrophage Raw 264.7 cells.
Ikeda O; Sekine Y; Kakisaka M; Tsuji S; Muromoto R; Ohbayashi N; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2007 Jul; 358(3):931-7. PubMed ID: 17512498
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
20. Signal-transducing adaptor protein-2 regulates integrin-mediated T cell adhesion through protein degradation of focal adhesion kinase.
Sekine Y; Tsuji S; Ikeda O; Sugiyma K; Oritani K; Shimoda K; Muromoto R; Ohbayashi N; Yoshimura A; Matsuda T
J Immunol; 2007 Aug; 179(4):2397-407. PubMed ID: 17675501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
